US Federal House Bill HR675

US Federal 2025-2026 Regular Session

• Introduced: 9/3/25
• Refer: 9/3/25

Caption

Expressing support for the designation of September 2025 as "National Prostate Cancer Awareness Month".

Impact

The resolution underscores the significant number of men diagnosed with prostate cancer and aims to promote early detection through screening methods such as digital rectal examination and prostate-specific antigen tests. These screenings are vital as they can detect the disease at earlier, more treatable stages, resulting in significantly improved survival rates. The message emphasizes the need for greater healthcare access and quality, which is particularly crucial as prostate cancer presents few noticeable early symptoms, leading many to delay seeking treatment until the disease has progressed.

Summary

House Resolution 675 expresses support for the designation of September 2025 as 'National Prostate Cancer Awareness Month.' The resolution highlights the importance of raising awareness concerning prostate cancer, which is the most commonly diagnosed non-skin cancer and the second leading cause of cancer-related deaths among men in the United States. By establishing this awareness month, the resolution aims to encourage education and screening for prostate cancer, particularly among high-risk groups, including African-American men and those with a family history of the disease.

Contention

While the resolution itself does not propose any binding legislation, it reflects an increasing recognition of prostate cancer's impact on public health and the economy. Notably, it calls on the people of the United States and various interest groups to take an active role in promoting awareness and fighting the effects of prostate cancer. This can involve public events or campaigns during National Prostate Cancer Awareness Month, encouraging individuals and organizations to play a part in supporting research and healthcare quality improvements for those affected by this disease.